Daikaffil Chemicals India Ltd. benchmarking: Perfomance to industry peers

Financial

	Daikaffil Chemicals	Eiko Lifesciences	Sunil Healthcare
Operational Metrics
Financials
5 yr Average ROE	6.39 %	-16.62 %	1.91 %
5yr average Equity Multiplier	1.55	2.12	2.47
5yr Average Asset Turnover Ratio	1.0	0.56	0.77
5yr Avg Net Profit Margin	2.14 %	-3.7 %	0.33 %
Price to Book	8.25	1.22	1.09
P/E	0.0	25.86	397.37
5yr Avg Cash Conversion Cycle	230.16 Days	61.48 Days	113.61 Days
Inventory Days	60.47 Days	214.38 Days	64.09 Days
Days Receivable	295.02 Days	57.98 Days	139.61 Days
Days Payable	76.92 Days	248.22 Days	139.86 Days
5yr Average Interest Coverage Ratio	-13.02	-0.09	1.69
5yr Avg ROCE	10.97 %	-109.51 %	9.44 %
5yr Avg Operating Profit Margin	5.52 %	-9.68 %	5.47 %
5 yr average Debt to Equity	0.05	0.3	0.9
5yr CAGR Net Profit	n/a	60.2 %	-18.44 %
5yr Average Return on Assets	4.25 %	-4.56 %	1.18 %
Shareholdings
Promoter Holding	52.65 %	37.17 %	73.53 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	21.46 %	22.49 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0